DK2049556T3 - Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme - Google Patents

Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme

Info

Publication number
DK2049556T3
DK2049556T3 DK07788320.5T DK07788320T DK2049556T3 DK 2049556 T3 DK2049556 T3 DK 2049556T3 DK 07788320 T DK07788320 T DK 07788320T DK 2049556 T3 DK2049556 T3 DK 2049556T3
Authority
DK
Denmark
Prior art keywords
inflammatory
allergic diseases
new macrolides
macrolides used
new
Prior art date
Application number
DK07788320.5T
Other languages
English (en)
Inventor
Johannes Laurenz Kellenberger
Juerg Dreier
Stefan Bernhard Reinelt
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK2049556T3 publication Critical patent/DK2049556T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK07788320.5T 2006-08-09 2007-08-08 Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme DK2049556T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06016591 2006-08-09
PCT/EP2007/058247 WO2008017696A1 (en) 2006-08-09 2007-08-08 New macrolides useful against inflammatory and allergic disseases

Publications (1)

Publication Number Publication Date
DK2049556T3 true DK2049556T3 (da) 2013-08-12

Family

ID=37067595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07788320.5T DK2049556T3 (da) 2006-08-09 2007-08-08 Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme

Country Status (16)

Country Link
US (1) US8173609B2 (da)
EP (1) EP2049556B1 (da)
JP (1) JP5254231B2 (da)
KR (1) KR101239490B1 (da)
CN (1) CN101511855B (da)
AU (1) AU2007283556B2 (da)
BR (1) BRPI0716408A2 (da)
CA (1) CA2658950C (da)
CY (1) CY1114481T1 (da)
DK (1) DK2049556T3 (da)
ES (1) ES2428874T3 (da)
MX (1) MX2009001140A (da)
PL (1) PL2049556T3 (da)
PT (1) PT2049556E (da)
WO (1) WO2008017696A1 (da)
ZA (1) ZA200900677B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098320A2 (en) 2008-02-08 2009-08-13 Basilea Pharmaceutica Ag Macrolides and uses of macrolides
JP5651019B2 (ja) * 2008-02-08 2015-01-07 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ 新規マクロライドおよびそれらの使用
EP2110375A1 (en) * 2008-04-14 2009-10-21 CHIESI FARMACEUTICI S.p.A. Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
AR077033A1 (es) * 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
CA2769551A1 (en) 2009-08-13 2011-02-17 Basilea Pharmaceutica Ag New macrolides and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE408614T1 (de) * 2000-08-22 2008-10-15 Basilea Pharmaceutica Ag Neue macrolide mit antibakterieller wirkung
US6756359B2 (en) 2001-07-03 2004-06-29 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
EP1430068A1 (en) * 2001-09-17 2004-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) * 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US20050142104A1 (en) * 2003-11-06 2005-06-30 Zeldis Jerome B. Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders
AU2003304705A1 (en) 2003-12-24 2005-08-03 Enanta Pharmaceuticals, Inc. 11-csubsituted erythromycin derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
EP1846430B1 (en) 2005-02-09 2009-04-01 Basilea Pharmaceutica AG New macrolides

Also Published As

Publication number Publication date
PT2049556E (pt) 2013-08-22
JP5254231B2 (ja) 2013-08-07
ZA200900677B (en) 2010-02-24
PL2049556T3 (pl) 2013-12-31
AU2007283556B2 (en) 2011-10-06
BRPI0716408A2 (pt) 2013-09-24
AU2007283556A1 (en) 2008-02-14
US8173609B2 (en) 2012-05-08
CN101511855B (zh) 2013-04-24
CA2658950A1 (en) 2008-02-14
CY1114481T1 (el) 2016-10-05
CN101511855A (zh) 2009-08-19
KR101239490B1 (ko) 2013-03-05
KR20090035639A (ko) 2009-04-09
EP2049556B1 (en) 2013-07-03
US20100120706A1 (en) 2010-05-13
ES2428874T3 (es) 2013-11-12
JP2010500329A (ja) 2010-01-07
WO2008017696A1 (en) 2008-02-14
CA2658950C (en) 2013-01-08
MX2009001140A (es) 2009-02-10
EP2049556A1 (en) 2009-04-22

Similar Documents

Publication Publication Date Title
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK1964570T3 (da) Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
BRPI0812367A2 (pt) Dispositivos interoclusais e respectivos métodos de fabrico
BRPI0807525A2 (pt) Dispositivo endo-cirúrgico e método
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2094842T3 (da) Nye laccaser, sammensætninger og anvendelsesfremgangsmåder
DK2029583T3 (da) Nye benzothiazinonderivater og anvendelse heraf som antibakterielle midler
ATE509020T1 (de) 3-cyano-4-(4-tetrahydropyranphenyl)pyridin-2- onderivate
BRPI0816907A2 (pt) Método e dispositivo
DK2081955T3 (da) Metastinderivater og anvendelse deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DE602007006745D1 (de) Sondenvorrichtung
DK2096167T3 (da) Aptamer mod midkin og anvendelse deraf
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK2185175T3 (da) MMP-9-regulatorer og anvendelser deraf
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
ES1069016Y (es) Dispositivo vaginal
ATE448431T1 (de) Chirurgische kassette
DK1849762T3 (da) Substituerede biphenylcarboxylsyrer og derivater deraf
FI20065834A0 (fi) Iskulaite
DK2246477T3 (da) Spunspæl med dobbelt t-form
CR10430A (es) Aminothiazoles and their uses
DE112009003766T8 (de) Sputter-Vorrichtung und Sputter-Verfahren
DE602006019321D1 (de) Matratze